BeStock  
Stocks › Biotechnology › OABI

OmniAb OABI

US equityMarket cap rank #3551Biotechnology
$4.56 +$0.21 (+4.83%)
Pre-market · Oct 8, 8:20 am ET · After hours $4.61 +1.10%
Open$4.35
Prev close$4.35
Day range$4.30 – $4.75
Volume1.50M
Market cap$662.98M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$13.42M+244.2% YoY
Operating profit-$6.64M+65.5% YoY
Net profit-$5.86M+63.1% YoY
Diluted EPS-$0.05+66.7% YoY
Free cash flow$2.57M+148.4% YoY
Operating cash flow$2.68M

Revenue, last 8 quarters

$4.2MSep '24$10.8MDec '24$4.2MMar '25$3.9MJun '25$2.2MSep '25$8.4MDec '25$14.4MMar '26$13.4MJun '26

Net profit, last 8 quarters

$-16.4MSep '24$-13.1MDec '24$-18.2MMar '25$-15.9MJun '25$-16.5MSep '25$-14.2MDec '25$-7.7MMar '26$-5.9MJun '26

Diluted EPS by quarter

-0.16Sep '24-0.12Dec '24-0.17Mar '25-0.15Jun '25-0.14Sep '25-0.11Dec '25-0.06Mar '26-0.05Jun '26

Free cash flow by quarter

$-6.7MSep '24$-3.9MDec '24$-16.1MMar '25$-5.3MJun '25$-9.9MSep '25$-5.7MDec '25$-5.1MMar '26$2.6MJun '26

Annual revenue

$23.3MFY20$34.7MFY21$59.1MFY22$34.2MFY23$26.4MFY24$18.7MFY25

Profitability & balance sheet

Gross margin98.3%
Operating margin-118.0%
Net margin-115.1%
Return on equity-17.0%
Return on assets-15.1%
Return on invested capital-16.6%
Current ratio4.80
Liabilities / assets10.3%
Cash & investments$52.00M
Total debt$14.94M
Net cash (debt)$37.06M

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $13.42M $14.43M $18.67M $8.38M $2.24M
Total Operating Revenue $13.42M $14.43M $18.67M $8.38M $2.24M
Cost of Revenue $610,000.00 $15,000.00 $303,000.00 $9,000.00 $29,000.00
Gross Profit $12.81M $14.41M $18.36M $8.37M $2.21M
Operating Expense $19.44M $22.24M $87.33M $24.13M $20.35M
Selling and Admin Expenses $6.65M $6.62M $29.22M $6.84M $6.78M
-General & Admin Expense $6.65M $6.62M $29.22M $6.84M $6.78M
Research & Development $9.59M $9.64M $47.75M $13.91M $10.38M
Depreciation & Amortization & Depletion $3.05M $6.03M $12.91M $3.23M $3.23M
-Depreciation & Amortization $3.05M $6.03M $12.91M $3.23M $3.23M
Other Operating Expenses $150,000.00 -$46,000.00 -$2.55M $157,000.00 -$34,000.00
Operating Profit -$6.64M -$7.83M -$68.97M -$15.77M -$18.14M
Net Non-Operating Interest Income (Expense) $434,000.00 $487,000.00 $2.66M $1.23M $462,000.00
Non-Operating Interest Income $434,000.00 $487,000.00 $2.66M $1.23M $462,000.00
Other Income (Expense) -$9,000.00 $77,000.00 $15,000.00 -$5,000.00 -$8,000.00
Other Non-Operating Income (Expenses) -$9,000.00 $77,000.00 $15,000.00 -$5,000.00 -$8,000.00
Pretax Profit -$6.21M -$7.27M -$66.29M -$14.55M -$17.69M
Tax -$353,000.00 $442,000.00 -$1.52M -$367,000.00 -$1.16M
Net Profit -$5.86M -$7.71M -$64.78M -$14.18M -$16.53M
Profit from Continuing Operations -$5.86M -$7.71M -$64.78M -$14.18M -$16.53M
Net Income to Parent Company -$5.86M -$7.71M -$64.78M -$14.18M -$16.53M
Net Income to Common Stockholders -$5.86M -$7.71M -$64.78M -$14.18M -$16.53M
Basic EPS -$0.05 -$0.06 -$0.57 -$0.11 -$0.14
Diluted EPS -$0.05 -$0.06 -$0.57 -$0.11 -$0.14

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $290.26M $293.65M $300.91M $300.91M $309.69M
Total Current Assets $66.01M $65.13M $65.34M $65.34M $66.35M
Cash and Cash Equivalents & Short-Term Investments $52.00M $49.07M $54.03M $54.03M $59.50M
-Cash and Cash Equivalents $24.34M $29.05M $25.52M $25.52M $28.54M
-Short Term Investments $27.66M $20.03M $28.50M $28.50M $30.96M
Receivables $10.33M $12.64M $7.39M $7.39M $3.10M
-Accounts Receivable $10.33M $12.64M $7.39M $7.39M $3.10M
Prepaid Assets $1.90M $2.02M – – $2.18M
Inventory $1.01M $920,000.00 – – $443,000.00
Other Current Assets $773,000.00 $472,000.00 $3.93M $3.93M $1.13M
Total Non-Current Assets $224.24M $228.53M $235.57M $235.57M $243.34M
Net PPE $22.94M $24.07M $24.97M $24.97M $29.40M
-Gross PPE $43.30M $44.01M $44.31M $44.31M $44.99M
-Accumulated Depreciation -$20.36M -$19.94M -$19.33M -$19.33M -$15.59M
Goodwill and Other Intangible Assets $200.05M $203.10M $209.13M $209.13M $212.36M
-Goodwill $83.98M $83.98M $83.98M $83.98M $83.98M
-Other Intangible Assets $116.07M $119.12M $125.15M $125.15M $128.38M
Other Non-Current Assets $1.26M $1.36M $1.47M $1.47M $1.59M
Total Liabilities $29.98M $31.00M $33.89M $33.89M $32.25M
Total Current Liabilities $13.76M $13.57M $16.25M $16.25M $13.28M
Payables $2.09M $1.65M $1.88M $1.88M $1.91M
-Accounts Payable $2.09M $1.65M $1.88M $1.88M $1.91M
Current Accrued Expenses $505,000.00 $604,000.00 $329,000.00 $329,000.00 $365,000.00
Short-Term Debt and Capital Lease Obligation $3.97M $3.94M $3.88M $3.88M $3.86M
-Current Capital Lease Obligation $3.97M $3.94M $3.88M $3.88M $3.86M
Current Deferred Liabilities $2.26M $2.94M $3.16M $3.16M $1.64M
Other Current Liabilities $1.06M $1.21M $1.22M $1.22M $876,000.00
Total Non-Current Liabilities $16.23M $17.44M $17.63M $17.63M $18.97M
Long Term Debt and Capital Lease Obligation $14.94M $15.73M $16.46M $16.46M $17.21M
-Long Term Capital Lease Obligation $14.94M $15.73M $16.46M $16.46M $17.21M
Non-Current Deferred Liabilities $1.19M $1.60M $785,000.00 $785,000.00 $1.17M
Other Non-Current Liabilities $94,000.00 $112,000.00 $393,000.00 $393,000.00 $595,000.00
Total Equity $260.27M $262.65M $267.03M $267.03M $277.44M
Stockholders' Equity $260.27M $262.65M $267.03M $267.03M $277.44M
Capital Stock $15,000.00 $14,000.00 $14,000.00 $14,000.00 $14,000.00
-Common Stock $15,000.00 $14,000.00 $14,000.00 $14,000.00 $14,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $440.02M $436.52M $433.18M $433.18M $429.43M
Retained Earnings -$179.75M -$173.89M -$166.18M -$166.18M -$152.00M
Gains/Losses Not Affecting Retained Earnings -$20,000.00 -$2,000.00 $12,000.00 $12,000.00 $5,000.00

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $2.68M -$4.91M -$36.46M -$5.67M -$9.76M
Net cash flow from continuing operations $2.68M -$4.91M -$36.46M -$5.67M -$9.76M
Net Income from Continuing Operations -$5.86M -$7.71M -$64.78M -$14.18M -$16.53M
Depreciation & Depletion & Amortization $4.22M $7.21M $21.75M $7.71M $4.66M
Deferred Tax -$345,000.00 $442,000.00 -$1.53M -$381,000.00 -$1.16M
Other Non-Cash Items $45,000.00 -$263,000.00 $1.09M $732,000.00 $9,000.00
Change in Working Capital $1.61M -$7.74M -$4.95M -$2.92M -$532,000.00
-Change in Receivables $2.37M -$4.92M $189,000.00 -$2.18M -$230,000.00
-Change in Prepaid Assets -$276,000.00 $512,000.00 -$1.11M -$787,000.00 -$457,000.00
-Change in Payables and Accrued Expense $977,000.00 -$2.52M -$231,000.00 $1.26M $280,000.00
-Change in Other Current Assets $94,000.00 $117,000.00 $628,000.00 $116,000.00 $138,000.00
-Change in Other Current Liabilities -$757,000.00 -$748,000.00 -$2.83M -$735,000.00 -$714,000.00
-Change In Other Working Capital -$800,000.00 -$178,000.00 -$1.60M -$589,000.00 $451,000.00
Net cash flow from investing -$7.62M $8.44M $6.47M $2.71M -$7.67M
Net Cash Flow from Continuing Investing Activities -$7.62M $8.44M $6.47M $2.71M -$7.67M
Net PPE Purchase and Sale -$110,000.00 -$167,000.00 -$565,000.00 -$9,000.00 -$182,000.00
Net Investment Purchase and Sale -$7.51M $8.60M $4.03M $2.72M -$7.48M
Financing Cash Flow $233,000.00 $0.00 $27.91M -$50,000.00 $27.68M
Net Cash Flow from Continuing Financing Activities $233,000.00 $0.00 $27.91M -$50,000.00 $27.68M
Proceeds from Stock Option Exercised $346,000.00 $0.00 $489,000.00 $148,000.00 $0.00
Ending Cash Balance $24.90M $29.61M $26.08M $26.08M $29.10M
Net Change in Cash -$4.71M $3.52M -$2.07M -$3.01M $10.26M
Beginning Cash Balance $29.61M $26.08M $28.16M $29.10M $18.84M
Free Cash Flow $2.57M -$5.08M -$37.02M -$5.68M -$9.95M
Gain/Loss from Continuing Operations – – -$3.00M $0.00 $0.00
Net Other Investing Changes – – $3.00M $0.00 $0.00
Net Common Stock Issuance – – $28.20M $0.00 –
Net Other Financing Charges – – -$774,000.00 -$198,000.00 -$515,000.00

Discussion

No comments yet — be the first to weigh in on OABI.

Leave a comment

Scroll to Top